Prasugrel Strategy Rolls Short DAPT and De-Escalation Into One

By News Health
1 month Ago

(MedPage Today) — In acute coronary syndrome (ACS), a prasugrel (Effient)-based antiplatelet regimen passed muster for reducing bleeding without compromising ischemic protection after percutaneous coronary intervention (PCI).
4D-ACS trial investigators…

Source link : https://www.medpagetoday.com/meetingcoverage/europcr/115729

Author :

Publish date : 2025-05-22 21:19:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Sleep and Alzheimer's; NIH Cuts to Brain Research; Novel CTE Report

Physical Activity and Rehabilitation in Duchenne Muscular Dystrophy

RFK Jr.'s Mass Firings Likely Unlawful and Must Be Halted, Judge Says

NHS Access Issues Driving Down Childhood Vaccine Uptake

Most on Wegovy a Year Later; Food Label Weight Stigma; Make Your Own GLP-1 Drugs?

Proton Pump Inhibitors and Hypertension; AI Fetal Cardiac Scans; 'Work Diet'